YUVEZZI Campaign Targets Presbyopia

Tenpoint Therapeutic’s new national campaign uses puppet characters to spotlight the everyday frustrations of presbyopia

1

Tenpoint Therapeutics launched a national campaign for YUVEZZI, a prescription eye drop for presbyopia, approved by the FDA.
2

The campaign, titled Friends of the Presbyopians, features puppets to illustrate frustrations with blurry close-up vision.
3

YUVEZZI is a dual-agent solution containing carbachol and brimonidine tartrate, approved for adults with age-related blurry near vision.
4

Presbyopia affects about 128 million adults in the US and approximately 2 billion people globally, typically starting around age 45.
5

YUVEZZI has shown to provide up to eight continuous hours of improved close-up vision, with common side effects including headache and eye irritation.

1